Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

耐而赞 - NMPA Drug Approval Details

Approvals/NMPA/Avalglucosidase Alfa for Injection

Approved

生物制品

Avalglucosidase Alfa for Injection

GENZYME CORPORATION🇨🇳 National Medical Products Administration

Approval Date: Sep 28, 2023
Approval ID: 8VIZYUSfENa
Company: GENZYME CORPORATION
Type: 生物制品

Approval Details

Approval Id: 8VIZYUSfENa
Approval Number: 国药准字SJ20230015
Generic Name: 注射用艾夫糖苷酶α
Generic Name En: Avalglucosidase Alfa for Injection
Trade Name: 耐而赞
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 100mg/瓶
Reg Date: 2023-09-28
Expired Date: 2028-09-27
Company Name: GENZYME CORPORATION
Production Company Name: GENZYME IRELAND LIMITED
Company Detail Path: /organization/genzyme-corporation
Production Company Detail Path: /organization/genzyme-ireland-limited

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Sep 28, 2023

Approval ID

8VIZYUSfENa

Type

生物制品

Back to NMPA Approvals